{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-008082","form_type":"8-K","ticker":"ASPI","cik":"0001921865","company_name":"ASP Isotopes Inc.","filed_at":"2023-11-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.402529+00:00","generated_at":"2026-06-08T22:46:03.010844+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"ASP Isotopes to acquire 51% of PET Labs for $2M; plans two new cyclotrons with GE Healthcare","bullets":["Acquired 51% of PET Labs for $2M; option to buy remaining 49% for $2.2M by Jan 2027.","Strategic relationship to produce and distribute medical isotopes in frontier markets using cyclotrons.","Plans to add two GE Healthcare cyclotrons in Pretoria and Cape Town, financed by third-party debt.","PET Labs currently operates one cyclotron in Pretoria, expanding radioisotope production."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-008082","json":"https://secwatch.observer/filing/0001477932-23-008082.json","markdown":"https://secwatch.observer/filing/0001477932-23-008082.md","text":"https://secwatch.observer/filing/0001477932-23-008082.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1921865/000147793223008082/0001477932-23-008082-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1921865/000147793223008082/aspi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T22:46:03.010844+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4429b1e39b2ece5498daea3fe4a08405debd33fd","claim":"ASP Isotopes Inc. entered into Share Purchase Agreement with Nucleonics Imaging Proprietary Limited valued at USD 2,000,000 for 51% of PET Labs shares, with option for remaining 49% for USD 2,200,000 (effective 2023-10-30).","evidence_excerpt":"On October 30, 2023, ASP Isotopes Inc. (the “Company”) entered into a Share Purchase Agreement (the “Purchase Agreement”) with Nucleonics Imaging Proprietary Limited, a company incorporated in the Republic of South Africa (“Seller”), relating to the purchase and sale of ordinary shares in the issued share capital of Pet Labs Pharmaceuticals Proprietary Limited, a company incorporated in the Republic of South Africa (“PET Labs”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1921865/000147793223008082/0001477932-23-008082-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Nucleonics Imaging Proprietary Limited"},{"label":"Value","value":"USD 2,000,000 for 51% of PET Labs shares, with option for remaining 49% for USD 2,200,000"},{"label":"Effective","value":"2023-10-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}